Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
57,285,340
-
Total 13F shares
-
52,880,406
-
Share change
-
+74,758
-
Total reported value
-
$1,749,297,467
-
Put/Call ratio
-
77%
-
Price per share
-
$33.09
-
Number of holders
-
267
-
Value change
-
-$144,709
-
Number of buys
-
120
-
Number of sells
-
144
Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (SUPN) as of Q2 2019
As of 30 Jun 2019,
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (SUPN) was held by
267 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
52,880,406 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, Champlain Investment Partners, LLC, DIMENSIONAL FUND ADVISORS LP, RICE HALL JAMES & ASSOCIATES, LLC, MACQUARIE GROUP LTD, GLENMEDE TRUST CO NA, Bank of New York Mellon Corp, and LOOMIS SAYLES & CO L P.
This page lists
267
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.